Blood Grants

2010 Mantle Cell Lymphoma Correlative Clinical Studies Grant

* $100K per year for 2 years: The Lymphoma Research Foundation (LRF) Mantle Cell Lymphoma Consortium seeks proposals for correlative clinical studies in mantle cell lymphoma. Applications to this initiative must be an adjunct to a major MCL research project and work in the clinical setting or with primary MCL patient samples. Innovative research by definition may uncover new questions and new areas requiring investigation. Basic funding often does not allow for additional, correlative studies to explore these areas. The intention of the current request for proposals is to fund such adjunct studies to complement and synergize with ongoing MCL trials within the NCI Cancer Cooperative Groups and/or the LRF-funded clinical projects. The applications should clearly focus on MCL and have a high degree of relevance to research questions pertinent to MCL.

RESEARCH OBJECTIVES:
To be considered for funding, an adjunct study should be:
1. Associated with an ongoing, clinical research project focused specifically on mantle cell lymphoma and funded by LRF or the NCI.
2. Intended to test a new hypothesis based on preliminary findings in the major study.
3. Capable of furthering the understanding of mantle cell lymphoma and/or its diagnosis and treatment.
Examples of eligible projects include, but are not limited to:
--Molecular and/or genetic profiling of patient-derived samples
--Identification of biomarkers
--Immunological studies
• Establishment of tissue arrays and other archival resources

Applications to this initiative must work in the clinical setting or with primary MCL patient samples.

ELIGIBILITY:

You may submit an application if your institution is a:
--Non-profit organization
--Public or private institution such as a university, college, hospital and/or laboratory

--Domestic or foreign institutions/organizations are eligible

For-profit entities are not eligible to apply for LRF funds, however, should a for-profit institution have a relevant therapeutic or research project, they should contact LRF management to discuss possible public-private partnerships.

Any individual with the skills, knowledge and resources necessary to carry out the proposed research is invited to work with their (eligible) institution to develop an application for support.

o Applications are due on August 15, 2010. Applications will be peer-reviewed, and applicants will be notified of results by November 2010.

All applications must be submitted electronically. LRF allows up to 25 percent overhead. Smaller overhead amounts are preferred. To apply for these grant opportunities, please go to https://proposalcentral.altum.com

For more information, please call: (800) 235-6848

2010 Mantle Cell Lymphoma Project Planning Grant

$25K for up to 2 years: The Lymphoma Research Foundation's Mantle Cell Lymphoma Consortium is seeking applications for project planning grants geared toward obtaining larger-scale research support from NIH/NCI (or another major funder). The purpose of these grants is to provide funds for MCL Consortium members and other MCL researchers to develop larger, longer-term proposals that are likely to become successfully funded from other sources, including Program Project Grants such as the POI. Multi-invenstigator, multi-site and/or mulit-disciplinary proposals are particularly encouraged.

ELIGIBILITY:
All principal investigators holding an academic faculty appointment, at non-profit organizations, or public or private institutions such as universities, colleges, hospitals, and laboratories, may apply for funding.

* Applications are due on May 15, 2010. Applications will be peer-reviewed, and applicants will be notified of results by Summer 2010. 

Lymphoma Research Foundation
115 Broadway, 13th Floor
New York, NY 10006

Phone: (212) 349-2910, (800) 235-6848
Fax: (212) 349-2886

American Society of Hematology Visitor Training Program

The purpose of the Visitor Training Program (VTP) is to help build hematology capacity in developing countries, ultimately improving patient care and/or research. The VTP provides funding for hematologists, scientists, or laboratory staff working in hematology in developing countries to receive training on a specific topic or technique for up to 12 weeks. Training is carried out in a clinic or laboratory under the mentorship of an ASH member anywhere in the world. Upon completion of the training, participants return to their home institution to implement the training and share their newfound knowledge with their colleagues.

Applications are now available for the 2010 Visitor Training Program.

Benefits
* ASH will fund approved costs for travel and living expenses (applicants must submit a budget).
* By implementing the training in their home institution, awardees will have the opportunity to increase hematology capacity for themselves and their colleagues, ultimately leading to improved patient care and/or research.
* By training with an ASH member, the awardee will participate in the rigorous scientific community of ASH.

Eligibility

Applicants
* Physicians, scientists, and hematology laboratory staff working in a hospital or a research institution in one of the countries defined as developing by ASH are welcome to apply.
* Applicants may be at any stage in their careers.
* Applicants do not need to be ASH members.

Application
* The primary focus must be on specific training in procedures that will benefit the applicant’s home institution.
* Relevant equipment and supplies must be available at the home institution.
* The VTP is intended to build capacity. Participants must implement the training at their home institution upon their return. Individual research projects will not be considered.
* Applications are reviewed by the ASH International Members Committee. Therefore, applications are not accepted from institutions where a member of the International Members Committee currently practices hematology.

For a current list of institutions, contact Clare Kelley at pckelley@hematology.org.

Host institution and mentor
* The host institution can be located anywhere in the world.
* The host mentor may be from any country.
* The host mentor must be a current ASH member in good standing on the day the application is submitted.

Deadlines
Application deadline: April 10, 2010
Award notification: by July 15, 2010

Questions?
If you have any questions or require any additional information regarding the ASH Visitor Training Program, please  contact Clare Kelley, International Programs Specialist, at pckelley@hematology.org or 202-776-0544, ext. 4902.

American Society of Hematology
2021 L Street NW, Suite 900
Washington, DC 20036

Phone 202-776-0544 | Fax 202-776-0545

American Society of Hematology Mentor Award

Mentorship is one of the most important determinants of a successful career in hematology, yet it is often a component of career development that, while prized by recipients, is rarely rewarded. In recognition of the value the Society places on mentorship, the ASH Mentor Award was created to reward outstanding mentors in the hematology community. Superb mentors from any of the different branches of hematology are eligible for this award, including adult or pediatric hematologists; academic or community practitioners; basic, clinical, or translational researchers; hematopathologists; transfusion medicine specialists; and individuals working in industry or government. It is anticipated that awardees will have had a sustained career commitment to mentoring, a significant positive impact on their mentees' careers, and through their mentees have advanced research and patient care in the field of hematology.

Each year one award in the amount of $5,000 and a plaque will be granted to an outstanding mentor in the basic sciences and one to an outstanding clinical investigator mentor. (The ASH Mentor Award Study Section reserves the right to not grant awards if no suitable nominations have been submitted.)

Award Criteria
This award is based on the training experiences and success of the nominee’s mentees, not the mentor’s personal career achievements. For the purpose of this award, mentoring is defined as the process of guiding, supporting, and promoting the training and career development of others. The key roles of a mentor include, but are not limited to providing:

* Intellectual growth and development
* Career development
* Professional guidance
* Advocacy
* Positive role modeling

Eligibility Criteria

Inclusion
1. All nominees and nominators must be members of ASH.
2. Nominees of all nationalities and all countries of residence are eligible; however, all application materials must be submitted in English.
3. Nominees may include adult or pediatric hematologists; academic or community practitioners; basic, clinical, or translational researchers; hematopathologists; transfusion medicine specialists; and individuals working in industry or government.
4. Nominees should have a sustained record of mentoring over time.
5. Nominators must be a mentee of the nominee, or colleagues who have personal knowledge of the nominee’s mentoring efforts.
6. Mentees should be actively involved in research, teaching, mentoring, or other leadership activities.
7. The nominator, primary, and secondary mentee must be three individuals.

Exclusion
1. Prior recipients of the ASH Mentor Award are ineligible for future awards.
2. Current members of the ASH Executive Committee, the ASH Awards Committee, or the ASH Mentor Award Study Section are ineligible.
3. Self-nominations and posthumous nominations will not be accepted.
4. Recipients of the William Dameshek Prize, Henry M. Stratton Medal, and E. Donnall Thomas Lecture and Prize are ineligible for the year they receive the award.

Nomination Packages

Nomination packages must be submitted by May 4, 2010, to:

ASH Training Manager
ASH Mentor Award
2021 L Street, NW, Suite 900
Washington, DC 20036

Nomination packages must include the following information:

1. The completed nomination form.
2. The nominee's curriculum vitae.
3. Three letters of recommendation.
* A letter written by the nominator that summarizes the nominee's impact on the training/careers of his/her mentees.
* Two letters written by the primary and secondary mentee (can be a former or current mentee) who can each provide a first-hand account of how the nominee influenced his or her career. Academic, clinical, and educational, achievements on the part of the mentee will all be considered important. These mentees must be willing to complete a structured telephone interview about the nominee's mentoring capacity.
* Optional: Up to three additional letters of support from junior and senior faculty will be accepted, but are not required. Ideally, at least one letter should be written by a mentee who can provide a first-hand account of how the nominee influenced his or her career. Academic, clinical, educational, and regulatory achievements on the part of the mentee will all be considered as important.

It is suggested that the nominees participate in the process of assembling the nomination package, since their mentoring achievements may have spanned many years, beyond the experience of individual mentees.
Nomination and Selection Process

Nominations may be made by any member of ASH, based on either having been mentored by the nominee or by personal observation of mentoring provided to others by the nominee. Nominators may be mentees of the nominee or colleagues who have personal knowledge of the nominee's mentoring efforts.

The ASH Mentor Award Study Section, which reviews nomination packages, includes, but is not limited to, four members from the ASH Trainee Council, one member from the ASH Educational Affairs Committee, one member from the ASH Awards Committee, one member from the ASH Committee on Practice, and one member from the ASH Committee on Training Programs.

Nomination packages will be forwarded to the Mentor Award Study Section for review. The selection process has a quantitative and a qualitative phase. During the initial quantitative phase, nomination packages are reviewed and scored by the members of the Study Section on a mentoring score card. Several members of the Study Section review each nomination package.

Nominations are scored based on the Award Criteria and the overall strength of the nomination package. The Study Section meets in June to review scores and decide on four to six finalists (broken out evenly in each of the two categories) to continue on to the qualitative component of the selection process.

During the qualitative phase of the selection process, the nominator and the two mentees are contacted for each finalist for a focused telephone interview. Interviews are conducted by a professional interviewer and are based on the "semi-structured interview" technique of qualitative research. The interviews explore the mentoring strengths and track-record of the nominee. Focused interview transcripts are prepared and forwarded to members of the Study Section by August. Final selections will be based on a consensus of the entire Study Section during a conference call that takes place in mid-August. The Study Section will encourage nominators of highly ranked, but unsuccessful, nominees to resubmit their application in subsequent years. Final selections are sent to the ASH Awards Committee and the ASH Executive Committee for final approval by the end of August. Awardees are notified in September.
Assessing the Selection Process

The selection criteria and evaluation tools were conceived in an effort to allow the Study Section a way to reach consensus, in a well-informed manner, about individuals who have consistently exemplified outstanding mentorship skills. Many of these skills are not easily assessed by academic rank or curriculum vitae. It is expected that awardees have outstanding academic records, but the aim of this selection process is to specifically address mentoring skills. To determine the utility and validity of the selection process, some nominees, nominators, referees, and awards committee members are asked to evaluate the nomination, selection, and award processes. These surveys are sent out and collated by ASH staff. Results are then reported back to the ASH Mentor Award Study Section and the appropriate procedures are modified accordingly.

2010 Selection Process Timeline

Nomination packages due. May 4, 2010

Study section to meet to review scores and decided on four to six finalists (broken out evenly in each category). June 2010

Focused interview transcripts will be prepared and forwarded to members of the ASH Mentor Award Study Section for review. August 2010

Study Section meets in a conference call to discuss final selections. August 2010

Final selections will be sent to the ASH Awards Committee and the ASH Executive Committee for final approval. August 2010

Winners notified. September 2010

Questions?
Questions about the ASH Mentor Award may be directed to training@hematology.org.

Excellence in Blood and Marrow Transplantation Award

Award: Monetary award of $1000 and a plaque.

Purpose: To recognize and support excellence in nurses engaged in blood and marrow transplantation

Nominee's Eligibility Criteria:
The candidate must meet the following criteria:

* Be a registered professional nurse and an active ONS member
* Have at least two years of oncology nursing experience
* Be a recognized expert in the field of blood and marrow transplantation (e.g., through publications, presentations, research, and peer review)
* Made a significant contribution to one or more of the following related to blood and marrow transplantation: professional/patient education, clinical practice, and/or nursing research
* Serves as a role model for other nurses.

Criteria:
The scoring criteria for judging this nomination is as follows:

* ONS involvement: Participation should include involvement at the local or national level.
o Includes membership on committees, holding office, or task force participation.
* Recognized expert in the field of blood and marrow transplantation, contributing to the development of blood and marrow transplantation.
o Includes articles in newsletters, journals, reports, video, multimedia, computer assisted instruction, chapters in books (do not include research here, include research in last criteria point).
* Significant contribution to the following areas:
o Professional/patient education related to blood and marrow transplantation
o Presentations
o Examples in letters of role modeling
o Specific educational interventions
o Program development
o Support groups
o Adjunct faculty to preceptor for students
o Community outreach
* Clinical practice related to blood and marrow transplantation:
o Theoretical concepts used
o Nursing process used
o Professional development of self and others
o Multidisciplinary collaboration
o Quality assurance
o Ethical decision-making used
o Reviews/applies nursing research
o Blood and marrow transplantation research

Application deadline: August 16, 2010, 5pm (ET).

For more information on any of the ONS awards, contact ONS at customer.service@ons.org. Both nominees and nominators will be notified once an application is received.

Oncology Nursing Society
125 Enterprise Drive Pittsburgh, PA15275
866-257-4ONS (866-257-4667)
412-859-6100
877-369-5497 (toll free fax)
412-859-6162 (fax)

Grant for Advanced Training Elective in Consultative Hematopathology and Solid Tumors

Available Funding: A maximum of $5,000 for the four week training rotation will be provided for each location, New York, Los Angeles, and Milan. Funding is available for up to 2 residents. Any expenses exceeding this amount are the responsibilities of the resident awardee.

About the Grant: This grant opportunity is for pathology residents and fellows in training who seek to gain advanced diagnostic experience in hematologic and solid tumor malignancies. Residents will have the opportunity to work in one of two state of the art laboratories located in Manhattan, New York or Los Angeles, California. There is only one laboratory in Milan, Italy and residents will work under the overall direction of Michael Dugan, MD, FCAP.

Location supervisors for New York will be Bruce Horten, MD, FCAP, and Henry Dong, MD, FCAP. Supervisors for Los Angeles will be Moacyr DaSilva, MD, FCAP, and Jess Savala, MD. The Milan, Italy supervisor will be Juan Rosai, MD, FCAP.

Expected Accomplishments for Residents:

1. Obtain hands-on experience with high volume, challenging hematologic and solid tumor diagnostic consultations. The training in Milan will be focused on diagnostic consultation, primarily solid tumor, with accompanying IHC under the direction of Dr. Juan Rosai.

2. Receive detailed instruction and hands-on experience (in NY or LA only) with
1. Flow cytometry
2. Molecular technologies
3. Cytogenetics
4. Fluorescence in situ hybridization (FISH)
5. Immunohisochemistry (IHC)

3. Participate in review of diagnostic consultations regarding rare or unusual tumors.

4. In Milan, the awardee will receive detailed exposure to rare cases forwarded to Dr. Rosai from around the world. This would be about 50% thyroid/mediastinal tumors and about 50% other cases. The case mix would be about 50% from U.S. and 50% from other countries. The fellow would receive experience in Immunohistochemistry (IHC) interpretation related to this cases and help prepare the reports generated by Dr. Rosai.

Eligibility Requirements:
* Applicant must be a Junior Member of CAP or have an application in process
* Applicant must have at least one year of AP training including at least six months of applicable surgical pathology training, and at least 2 months of hematopathology related training.
* Additional experience in hematopathology or genetics preferred.

Selection Criteria:
Application will be judged on the following:

* Merit of application and narrative
* Education value to the applicant
* Applicant background and current knowledge of pathology practice
* Program director’s recommendation

Reporting Requirements

* After completion of rotation, the grant recipient(s) must submit a report and evaluation of the experience to CAP Foundation which will be shared with Genzyme Genetics.
* The CAP Foundation may communicate the results of the completed project to CAP resource committees and Genzyme Genetics Medical Directors who are best positioned to use them. Copies of any communications sent will be mailed to the award recipient.
* Recipients are to submit a photo(s) and share their experience in writing with others.
* The grant recipient(s) may submit an abstract of his/her research experience or project to the CAP and/or other pathology related annual meetings.

Application Guidelines: (all material must be typed)
Deadline: October 1

1. Completed Application Form
2. A current curriculum vita
3. A letter of recommendation from the director of the applicant’s residency program indicating that salary and benefits will be supported during the award period
4. A narrative, not to exceed two pages, describing the:
1. Applicant’s interest in fellowship training area, why this experience is desired, and how it will enhance their training in pathology
2. Description of any previous experience that will be helpful to fulfill the elective objectives
3. Benefit to society and the practice of pathology that this experience will provide
4. Why the Foundation support is needed and what other means of support are available

NOTE: Applicants must select a first and second choice for training locations from Manhattan, Los Angeles, or Milan. If selecting Milan, Italy, candidates must hold a valid U.S. passport and be eligible for a non-working visitor’s visa.

Candidates must be prepared to pay all expenses for their stay in NY, LA or Milan which exceed the amount provided by this grant. This typically might include food, ancillary travel or entertainment expenses, or could including housing expenses that exceed the amount provided by CAP fellowship award.

Mail applications to:
College of American Pathologists Foundation
325 Waukegan Road
Northfield, Illinois 60093-2750

OR

By Email: capfdn@cap.org
By Fax: 847.832.8324
Questions? 800.323.4040 x7324

Histiocytosis Association of America Request for Proposals

The Histiocytosis Association of America is a nonprofit organization dedicated to raising awareness about histiocytic disorders, providing educational and emotional support, and funding research leading to better treatments and a cure. Proposals are being accepted for research into the causes and mechanisms of these disorders and improved means of treatment.

The maximum grant award amount is $50,000 USD

Proposals will be evaluated on the basis of scientific innovation/impact, feasibility, and relevance to histiocytic disorders. Additionally, it is desirable that funding from the HAA act as ‘seed funds’ for future grant applications to larger funding organizations, such as the NIH or government health ministries.

The histiocytoses are a group of rare disorders involving macrophages and/or dendritic cells. The etiology of this diverse group of disorders is still being clarified, though some are clearly of genetic and/or immunologic origin.

Listed below are some areas of interest; however, all relevant proposals are encouraged and will be considered.

Mechanisms of disease pathogenesis in LCH and HLH
Immunologic dysfunction as it may relate to histiocytic disorders
Biology of dendritic cells, macrophages, or lymphocytes in the pathogenesis of histiocytic disorders such as Hemophagocytic Lymphohistiocytosis (HLH) or Langerhans cells histiocytosis (LCH)
Cytogenetic abnormalities in LCH and other histiocytic disorders
Studies of genetic defects underlying HLH
Studies of surface antigen profile of LCH lesional cells
Cytokine production in histiocytic disorders
Mechanism of dendritic cell homing
CNS pathology in histiocytic disorders
Marker studies for hemophagocytic syndromes
Focused studies on rare histiocytic disorders: Erdheim-Chester disease,
Juvenile xanthogranuloma, Sinus histiocytosis with massive
lymphadenopathy
Langerhans cell histiocytosis in adults

Applications Must be Received by July 1, 2010

Grants To Be Awarded: November 2010

Applications accepted by email only: grants@histio.org

Histiocytosis Association of America
332 North Broadway
Pitman, New Jersey 08071 USA

General Email: Association@histio.org

Toll Free: 1 800-548-2758
In US and Canada only

Phone: +1 856-589-6606
Fax: +1 856-589-6614

Salvatore E. Quinci Foundation Scholarship

Complete Application Must Be Received no later than Friday, April 2, 2010

Criteria for eligibility for scholarships (Two (2) - $ 2,000. scholarships) (Criteria may be revised yearly):

• Are diagnosed with hemophilia or other bleeding disorder – need documents from hospital or treatment center confirming the diagnoses
• Acceptance by an accredited university, college, or vocational/technical school.
• Scholarship must be used for tuition, books, housings, or other school associated costs.
• Completion of scholarship application, including transcripts and letters of recommendation. Incomplete or late applications will not be considered.
• Include any additional information which you feel is pertinent.
• Salvatore E. Quinci Foundation reserves the right to make the final decision.

Application Process:
• Complete application, including all letters of recommendation and transcripts – must be received no later than Friday, April 2, 2010.
• Include a 1-page Written Statement. Discuss your future educational and vocational/career goals and how you plan to use the scholarship money.
• Request copies of your official transcript of your high school or college grades.
• Get two (2) letters of recommendation. One letter of recommendation must be from a teacher from whom you took a class.
• Provide documentation from hospital, treatment center, or physician confirming that you have been diagnosed with hemophilia or other bleeding disorder
• All documentation (application, transcripts, recommendations, verification that the applicant has hemophilia, essay, etc.) must be enclosed and sent as one complete package.

These scholarships will be awarded based on quality of application, how well the applicant meets the criteria, and how well rounded applicant is. High school grades/college grades and financial need may also be considered.

Salvatore E. Quinci Foundation Inc.
178 Florence Street.
Melrose, MA 02176

Rachel Warner Scholarship Program

COTT's Rachel Warner Memorial Scholarships are for educational use, from high school through graduate school. They are for individuals with any bleeding disorder. Awards are modest, seldom exceeding a thousand dollars. The May 1 deadline each year ensures time for awards and for planning additional resources for the year.

The Committee of Ten Thousand is proud to honor Rachel Warner through this Memorial Scholarship Fund. The fund awards scholarships to individuals who are committed to pursuing higher education in order to better themselves, thereby enhancing our community. The is a component of what Rachel believed in, stood for, and tirelessly advocated for: individual and community empowerment.

Committee of Ten Thousand
236 Massachusetts Ave. NE # 609
Washington , D.C. 20002-4971
(800) 488-2688 (202) 543-0988 tel
(202) 543-6720 fax
cott-dc@earthlink.net

Due May 1, 2010

National Cornerstone Healthcare Services Inc. Scholarship Award Program

NCHS is committed to support individuals desiring to receive education and succeed as adults in the community. We have a scholarship program from $500 to $1000.00 per year awarded to a person or person(s) associated with the bleeding disorders community.

The Awards committee oversees the scholarship program. The committee determines the number and amount of the awards based on a number of criteria including but not limited to academic merit, employment status, narrative, reference letters, financial need and impact of the bleeding disorders community.

Requirements for Application

1. Must be planning to attend an accredited technical school, college or university.
2. Must be a person diagnosed with a bleeding disorder, parent, spouse, partner, child or sibling of a person diagnosed with a bleeding disorder.
3. Must have a grade point average (GPA) of 2.5 of a 4.0 scale, or higher during entire senior year of high school.
4. Submit Two (2) letters of support; one must be from a teacher or instructor. The second from an employer, church leader, health care provider, or other professional person involved in your life.

The Award Committee meets annually in April; all applications must be received by April 1st. Incomplete applications will not be considered. The applicant awarded the scholarship will by notified by May 1st.

National Cornerstone Healthcare Services Inc.
24747 Redlands Blvd Ste B
Loma Linda, CA 92354

Toll Free Number:
1-877-616-6247
Fax:1-877-777-5717

inquiry@nc-hs.com